## Abstract A human cytomegalovirus (HCMV) glycoprotein B (gpUL55) DNA vaccine has been evaluated in BALB/c mice. Intramuscular immunization of these mice with pRc/CMV2โgB resulted in the generation of high levels of gpUL55โspecific antibody (geometric mean titer [GMT] 1:8900) and neutralizing anti
Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response
โ Scribed by Marcin Kwissa; Erik B. Lindblad; Reinhold Schirmbeck; Joerg Reimann
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 406 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0946-2716
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs
## Abstract ## Background The antigenโspecific immune response is dependent not only on the properties of the antigens, but also on their encounter with antigenโpresenting cells. A previous study showed that the spleen produced a large amount of transgenes after direct tissue injection of plasmid
A combined vaccine against measles (Edmonston-Zagreb 19 strain), mumps (Rubini strain) and rubella (Wistar RA 27/3 strain) was administered to a group of 46 children aged 10-12 months simultaneously with booster doses of compulsory diphtheria-tetanus toxoid and oral poliovirus vaccine. A second grou
## Abstract ## Background In the present study, we evaluated the safety of CIGBโ230, a novel vaccine candidate based on the mixture of a plasmid for DNA immunization, expressing hepatitis C virus (HCV) structural antigens, with a recombinant HCV Core protein. ## Methods Fifteen HCV chronicallyโi
## Abstract We previously reported identifying SOX6 as a glioma antigen by serological screening using a testis cDNA library. Its preferential expression and frequent IgG responses in glioma patients indicate that SOX6 may be a useful target for immunotherapy. To examine whether cytotoxic Tโlymphoc